Clinical data | |
---|---|
Other names | 2α-Chloro-5α-androstan-17β-ol-3-one 3-O-(p-nitrophenyl)oxime; 2α-Chloro-4,5α-dihydrotestosterone 3-O-(p-nitrophenyl)oxime; 2α-Chloro-3-(p-nitrophenoxy)imino-5α-androstan-17β-ol |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C25H33ClN2O4 |
Molar mass | 461.00 g·mol−1 |
3D model (JSmol) | |
| |
|
Nisterime (INN ), also known as 2α-chloro-4,5α-dihydrotestosterone 3-O-(p-nitrophenyl)oxime or as 2α-chloro-5α-androstan-17β-ol-3-one 3-O-(p-nitrophenyl)oxime, is a synthetic anabolic-androgenic steroid (AAS) and a derivative of dihydrotestosterone (DHT) that was never marketed.[1] The C17α acetate ester of nisterime, nisterime acetate (ORF-9326), also exists and was developed as a postcoital contraceptive but was similarly never marketed.[1]
See also
References
- 1 2 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 876–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.